[1]
“Expanding Therapeutic Applications of Tofacitinib in Immune-Mediated Skin Disorders: A Comprehensive Review”, J of Skin, vol. 9, no. 2, pp. 2175–2183, Mar. 2025, doi: 10.25251/skin.9.2.3.